| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.27 | 3e-11 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-11 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.35 | 4e-11 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.3 | 5e-11 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-11 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.27 | 7e-11 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.27 | 8e-11 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-11 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-10 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-10 |